🇺🇸 FDA
Patent

US 11273214

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 11273214 (Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K2039/575